|
Anguita Sanchez M, Bertomeu Martinez V, Ruiz Ortiz M, Cequier Fillat A, Roldan Rabadan I, Muniz Garcia J, Badimon Maestro L, Esteve Pastor MA, Marin Ortuno F; FANTASIIA study investigators. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study. Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):14-20. doi: 10.1016/j.rec.2019.02.021. Epub 2019 May 31. English, Spanish. PubMed PMID: 31160265.
AÑO: 2020; IF: 4.753
|
31160265
|
Rivera-Caravaca JM, Esteve-Pastor MA, Camelo-Castillo A, Ramirez-Macias I, Lip GYH, Roldan V, Marin F. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opin Pharmacother. 2020 Oct;21(15):1867-1881. doi: 10.1080/14656566.2020.1789099. Epub 2020 Jul 13. PubMed PMID: 32658596.
AÑO: 2020; IF: 3.889
|
|
Carrillo-Aleman L, Marin F, Rivera-Caravaca JM, Vicente-Ibarra N, Candela-Sanchez E, Esteve-Pastor MA, Lozano T, Sandin-Rollan M, Pernias-Escrig V, Macias M, Quintana-Giner M, Veliz A, Orenes-Pinero E, Martinez-Martinez JG, Ruiz-Nodar JM. Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis. Clin Drug Investig. 2019 Mar;39(3):275-283. doi: 10.1007/s40261-018-0736-z. PubMed PMID: 30623372.
AÑO: 2019; IF: 2.267
|
|
Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Veliz-Martinez A, Orenes-Pinero E, Macias-Villanego MJ, Lozano T, Carrillo-Aleman L, Vicente-Ibarra N, Pernias-Escrig V, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12. PubMed PMID: 30207603.
AÑO: 2019; IF: 2.425
|
|
Rivera-Caravaca JM, Marin F, Vilchez JA, Galvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldan V. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14. PubMed PMID: 31084333.
AÑO: 2019; IF: 10.17
|